Real-world effectiveness of recombinant zoster vaccine in self-identified Chinese individuals aged ≥50 years in the United States

• Main Authors: Ana Florea (Author), Lina Sy (Author), Lei Qian (Author), Bradley Ackerson (Author), Yi Luo (Author), Jun Wu (Author), Yanjun Cheng (Author), Jennifer Ku (Author), Leticia Vega Daily (Author), Harpreet Takhar (Author), Jeannie Song (Author), Elizabeth Chmielewski-Yee (Author), O'Mareen Spence (Author), Harry Seifert (Author), Driss Oraichi (Author), Hung Fu Tseng (Author)
• Format: Book
• Published: Taylor & Francis Group, 2024-12-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

ABSTRACTWe evaluated the vaccine effectiveness (VE) of two doses of recombinant zoster vaccine (RZV) against herpes zoster (HZ) and postherpetic neuralgia (PHN) in Chinese adults at Kaiser Permanente Southern California (KPSC). Chinese KPSC members were identified based on self-reported ethnicity or...